- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lipella Pharmaceuticals Inc (LIPO)
Lipella Pharmaceuticals Inc stock price live, this page displays OTC LIPO stock exchange data. View the LIPO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lipella Pharmaceuticals Inc real time stock price chart below.
What Is the Lipella Pharmaceuticals Inc Stock Price Today?
The Lipella Pharmaceuticals Inc stock price today is 0.0005.
What Is the Stock Symbol for Lipella Pharmaceuticals Inc?
The stock symbol for Lipella Pharmaceuticals Inc is "LIPO."
What Stock Exchange Does Lipella Pharmaceuticals Inc Trade On?
Lipella Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Lipella Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Lipella Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIPO quote. (ISIN: US53630L2097)
What Is the Lipella Pharmaceuticals Inc Stock Price Today?
The Lipella Pharmaceuticals Inc stock price today is 0.0005.
What Is the Stock Symbol for Lipella Pharmaceuticals Inc?
The stock symbol for Lipella Pharmaceuticals Inc is "LIPO."
What Stock Exchange Does Lipella Pharmaceuticals Inc Trade On?
Lipella Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Lipella Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Lipella Pharmaceuticals Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIPO quote. (ISIN: US53630L2097)
OTC Markets
Currency in USD
0.0005
0.0000(0.00%)
Delayed Data·
Fair Value
An estimate of a Lipella Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0005
0.0005
52 wk Range
0.0002
0.6407
LIPO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Lipella Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00050.0005
52 wk Range
0.00020.6407
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIPO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lipella Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Lipella Pharmaceuticals delisted from Nasdaq- Investing.com
Lipella Pharmaceuticals CEO issues letter following delisting- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Sep 02, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare LIPO to Peers and Sector
Metrics to compare | LIPO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIPOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −5.5x | −0.4x | |
PEG Ratio | 0.00 | 0.08 | 0.00 | |
Price/Book | 0.0x | 2.4x | 2.6x | |
Price / LTM Sales | 0.0x | 92.5x | 3.0x | |
Upside (Analyst Target) | - | 130.3% | 49.0% | |
Fair Value Upside | Unlock | −1.3% | 6.5% | Unlock |
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lipella Pharmaceuticals (LIPO) Stock Price Today?
The Lipella Pharmaceuticals stock price today is 0.0005 USD.
What Stock Exchange Does Lipella Pharmaceuticals Trade On?
Lipella Pharmaceuticals is listed and trades on the OTC Markets.
What Is the Stock Symbol for Lipella Pharmaceuticals?
The stock symbol for Lipella Pharmaceuticals is "LIPO."
What Is the Lipella Pharmaceuticals Market Cap?
As of today, Lipella Pharmaceuticals market cap is 2.3100K USD.
What Is Lipella Pharmaceuticals's Earnings Per Share (TTM)?
The Lipella Pharmaceuticals EPS (TTM) is -1.7592.
When Is the Next Lipella Pharmaceuticals Earnings Date?
Lipella Pharmaceuticals will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is LIPO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Lipella Pharmaceuticals Stock Split?
Lipella Pharmaceuticals has split 1 times.
What is the current trading status of Lipella Pharmaceuticals (LIPO)?
As of Sep 08, 2026, Lipella Pharmaceuticals (LIPO) is trading at a price of 0.0005 USD, with a previous close of 0.0005 USD. The stock has fluctuated within a day range of 0.0005 USD to 0.0005 USD, while its 52-week range spans from 0.0002 USD to 0.6407 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.